23-07-2022, Pfizer India has signed a MOU (Memorandum of Understanding) with Max Super Specialty Hospitals to provide Fellowships to young doctors in 17 Max Specialty Hospitals spread across 4 states of India. The goal of the Fellowships is to understand and establish drug efficacy in proven therapies by mining real world evidence from Electronic Patient Records.
The big focus of this exercise is to bolster the principal pillars of public health in India – prevention, treatment and disease management. Additionally, the two organizations also interpret this collaboration as a window to build centres of excellence (CoE) in rare diseases – featuring RWE studies, capability-building workshops and Fellowship programs.
For the Fellows, this presents a unique opportunity to pick up precious insight, recognition and funding/sponsorships. Selection parameters for the Fellows will be decided by medical and research specialists at Max Healthcare. Technical and financial support to the initiative will come from Pfizer.
For Pfizer, this is a strategic move to build a future-ready ecosystem that syncs industry and academia to lift benchmarks of medical research in the country.
Addressing the media on the occasion, Dr Sandeep Budhiraja (Group Medical Director, Max Healthcare) shared, “Real-world evidence is becoming increasingly important in healthcare decision making. It has the potential to provide invaluable insights and work in synergy with other emerging developments such as a greater use of data science and genomics. Together, these efforts can transform the way we look at modern medicine. It gives us immense pleasure to collaborate with Pfizer India, which has taken significant strides into several areas of cutting-edge research, with the aim to solve critical scientific problems.”
*This press release is published by VOH team.*
Medanta Gurugram organizes initiatives to strengthen awareness around colorectal
Metropolis' MedEngage Scholarship Program recognizes 250 medical students with S
AMRI Hospitals Kolkata set to be acquired by The Manipal Group
Dr Nitish Shetty appointed CEO of Aster DM Healthcare (India Business)
Psoriasis drug launch marks Eli Lilly’s entry into dermatology domain
SAMRIDH Healthcare invests in Critical Care Hope to catalyze tele-ICUs across th
Health Check on Wheels: Apollo Hospitals Launches Gujarat’s First Fully-equipp
Steven Mou to steer Mindray’s ‘India Mission’ as Managing Director
Making Robotics Mainstream: HCG Hospitals Collaborates with Us-Based Intuitive t
Dr. Rajeev Singh Raghuvanshi appointed Drugs Controller General of India
Accurex BGMS (Blood Glucose Monitoring System) Factory Inauguration at Andhra Pr
VOH: Incubator Driving Innovation and Improving Access to Healthcare in India
Augnito Launches Its Developer Portal To Abridge Integration Timelines
MediBuddy acquires ‘vHealth by Aetna’, the India health business of Aetna In
Ayurveda in MBBS Curriculum?
View All